arrow
S

Stephen Clarke

royal north shore hospital
H指数:79
被引数:3.0万
浏览量:0

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Pretreatment FDG-PET Biomarkers Predict Regional and Distant Failure but Not Local Recurrence Following Modern use of Stereotactic Body Radiotherapy for Early-Stage Non-Small Cell Lung Cancer

FDG-PET预治疗生物标志物可预测接受现代立体定向体放射治疗的早期非小细胞肺癌的区域和远处失败,但不能预测局部复发

2026-10-080
PRE
DPYD genotype-guided dose personalisation for fluoropyrimidine-based chemotherapy prescribing in solid organ cancer patients in Australia: GeneScreen 5-FU study protocol

DPYD基因型指导的剂量个性化用于澳大利亚实体器官癌患者的氟嘧啶化疗处方: GeneScreen 5-FU研究方案

2024-11-081
OAAI
Advancing Global Health Equity in Oncology Clinical Trial Access
2024-09-240
PRE
DNA liquid biopsy-based prediction of cancer-associated venous thromboembolism
2024-08-150
OAAI
A Phase II trial of alternating osimertinib and gefitinib therapy in advanced EGFR-T790M positive non-small cell lung cancer: OSCILLATE

奥希替尼和吉非替尼交替治疗晚期EGFR-T790M阳性非小细胞肺癌的II期试验: 振荡

2024-02-286
OAAI
First-line chemoimmunotherapy and immunotherapy in patients with non-small cell lung cancer and brain metastases: a registry study
2024-02-074
OAAI
Anti-PD-1 Monoclonal Antibodies (mAbs) Are Superior to Anti-PD-L1 mAbs When Combined with Chemotherapy in First-Line Treatment for Metastatic Non-Small Cell Lung Cancer (mNSCLC): A Network Meta-Analysis

Anti-PD-1单克隆抗体 (mab) 联合化疗一线治疗转移性非小细胞肺癌 (mNSCLC) 优于Anti-PD-L1单克隆抗体: 一项网状Meta分析

2023-06-262
OAAI
The Prognostic and Predictive Role of the Neutrophil-to-Lymphocyte Ratio (NLR), Platelet-to-Lymphocyte Ratio (PLR), and Lymphocyte-to-Monocyte Ratio (LMR) as Biomarkers in Resected Pancreatic Cancer

中性粒细胞与淋巴细胞比率 (NLR),血小板与淋巴细胞比率 (PLR) 和淋巴细胞与单核细胞比率 (LMR) 作为生物标志物在切除的胰腺癌中的预后和预测作用

2023-03-0221
OAAI
A Multi-Center Real-World Experience of IMpower150 in Oncogene Driven Tumors and CNS Metastases

IMpower150在癌基因驱动的肿瘤和CNS转移中的多中心真实世界经验

2022-12-014
PRE